Pharmacy Times
AUGUST 19, 2022
Douglas Hoey, PharmD, MBA, CEO of National Community Pharmacists Association (NCPA), discusses potential causes and solutions for the current staffing issues facing so many community pharmacies.
The Honest Apothecary
AUGUST 19, 2022
It is my conviction that managers really do make all the difference in the world. Great managers get great results and build great teams. Bad managers don’t. But it is also my conviction that managers generally mirror the leadership culture created by those they report to. There is, if you will, a “trickle down” effect in the style and priorities of your management.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 19, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, discussed how mRNA vaccines could change the treatment landscape for respiratory illnesses.
The Guardian - Pharmaceutical Industry
AUGUST 19, 2022
Unlike jabs, nasal vaccines target the respiratory tract, the body’s first line of defence against infection People who receive a Covid booster dose in the UK next month will be among the first in the world to receive Moderna’s dual-variant vaccine , which protects against two strains of the virus. But scientists say there is a misconception that this latest vaccine is an upgrade on what has come before.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 19, 2022
Treatment with empagliflozin also found to improve cardiac geometry, myocardial mechano-energetic efficiency, and cardiac function.
DiversifyRx
AUGUST 19, 2022
Thank you to everyone who joined us for the Pharmacy Profit Summit 2022! We are still amazed at the lineup of extraordinary speakers at the summit. . Our event did sell out. We know that not everyone who wanted to attend could; even some with tickets got the dreaded positive test and couldn’t make it. In this blog, we will cover some of the highlights of the summit speakers and how you can learn more about them!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 19, 2022
US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers with leftover stock – is branching out into antivirals with the help of an $8 million fundraising. The cash injection will be used to launch a telehealth service that promises to provide prescriptions and services to patients regardless of their ability to pay.
Pharmacy Times
AUGUST 19, 2022
Auvelity uses the first new oral mechanism of action for major depressive disorder in more than 60 years.
Board Vitals - Pharmacist
AUGUST 19, 2022
CCRN certification is a special certification granted by the American Association of Critical Care Nurses (AACN). CCRN certification is valuable for nurses, as it allows RNs to care for patients in acute care and/or critical care setting. We’ve compiled some of the most frequently asked questions about CCRN certification to help you prepare for the exam and maintain your licensure.
Pharmacy Times
AUGUST 19, 2022
Ed Cohen, PharmD, FAPhA, drives a discussion around the new inclusion of infants as young as 6 months old within the COVID-19 vaccine recommendations and how to educate parents on the topic.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Luxe Pharmacist
AUGUST 19, 2022
Hello friends, I cannot wait for my girlfriends bachelorette this weekend in Miami! (Currently publishing this from the airport). I’m expecting a lot of heat given that it’s mid August, so I figured I may as well bring the heat as well! I’m sharing everything I packed and more if you need some inspiration for an upcoming bachelorette trip, date night, girls night out or tropical vacay.
European Pharmaceutical Review
AUGUST 19, 2022
Rising demand for therapeutics, especially in developing markets, is expected to expand the global pharmaceutical contract manufacturing market to $130.2 billion by 2026. The market was valued at approximately $100 billion in 2020. According to market research , factors promoting the 4.6 percent compound annual growth rate (CAGR) of the market include the increasing commercialisation of generics and emerging technologies and small biotechs with limited or no production capabilities driving devel
Pharmacy Times
AUGUST 19, 2022
Strategies for pediatric-specific care are explored, with an emphasis on vaccine advocation and administration geared toward parents and caregivers.
Pharmaceutical Technology
AUGUST 19, 2022
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has provided interim policy recommendations for the usage of French company Valneva’s Covid-19 vaccine, VLA2001. According to the recommendations, two 0.5ml intramuscular doses of the vaccine are intended to be given as part of the initial dosing regimen. The second dose should be given a minimum of 28 days following the first shot. .
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 19, 2022
Oncology pharmacists must think critically about the digital experience they give patients.
Pharmaceutical Technology
AUGUST 19, 2022
The European Commission (EC) has granted approval for Celltrion Healthcare ’s Vegzelma (CT-P16) to treat metastatic breast cancer, advanced and/or metastatic renal cell cancer, non-small cell lung cancer, ovarian cancer, metastatic carcinoma of the colon or rectum and cervical cancer. Vegzelma (CT-P16) is a bevacizumab biosimilar referencing Genentech’s Avastin, which is approved in the EU.
Pharmacy Times
AUGUST 19, 2022
Kcentra is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy in adult patients with acute major bleeding.
Pharmaceutical Technology
AUGUST 19, 2022
The UK National Institute for Health and Care Excellence (NICE) has r ecommended Vifor Fresenius Medical Care Renal Pharma’s Tavneos (avacopan) plus rituximab or cyclophosphamide to treat adults with two ANCA-associated vasculitis (AAV) forms. The treatment is indicated for severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), which are the two forms of AAV.
Pharmacy Times
AUGUST 19, 2022
The treatment regimen is first in more than 20 years to significantly improve outcomes in individuals with the fast-growing cancer, according to the company.
pharmaphorum
AUGUST 19, 2022
The European Commission has approved Oncopeptides’ Pepaxti in combination with dexamethasone for multiple myeloma patients with so-called triple class refractory disease – in other words those who don’t respond to all three of the major classes of treatment for the blood cancer. The approval means that Pepaxti (melphalan flufenamide) can now be used as a rescue therapy for adults with multiple myeloma who have previously failed treatment with at least one proteasome inhibitor, one im
Pharmacy Times
AUGUST 19, 2022
Andrew Barnell, MBA, CEO and co-founder of Geneoscopy, discusses his meeting at the White House on President Biden’s Cancer Moonshot initiative.
pharmaphorum
AUGUST 19, 2022
Reeling from the recent failure of its lead product in a pivotal trial, Nordic Nanovector has formally started a restructuring process and called in investment bank Carnegie to help explore its options. The Norwegian biotech was hit hard in July when the PARADIGME study of Betalutin ( 177 Lu lilotomab satetraxetan) – an anti-CD37 antibody radionuclide conjugate being tested as a third-line therapy for patients with follicular lymphoma – was abandoned after being plagued with recruitment issues.
Pharmacy Times
AUGUST 19, 2022
Researchers suggest that immune checkpoint inhibitors significantly preserve the quality of life in patients with cancer.
pharmaphorum
AUGUST 19, 2022
Australia’s CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial year which ends on 30 June next year. The VANGUARD trial of garadacimab, a Factor XIIa inhibitor, compared a subcutaneous injection of garadacimab given every four weeks to placebo on its ability to prevent the swelling attacks that are a key feature of HAE.
Pharmacy Times
AUGUST 19, 2022
Resources for health care professionals include FDA’s patient eligibility screening checklist tool for prescribers.
pharmaphorum
AUGUST 19, 2022
Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid drugs. The German pharma acquired rights to the TRPV1 agonist also known as MTX-071 last year when it acquired Swiss biotech Mestex, and has started dosing patients in one of three planned phase 3 trials in osteoarthritis of the knee.
Pharmacy Times
AUGUST 19, 2022
Using specific data and technology can help advance targeted recruitment goals for trials.
pharmaphorum
AUGUST 19, 2022
pharmaphorum Editor-in-Chief Jonah Comstock welcomes Amy Abernethy, president of Verily’s Clinical Studies Platforms and Jennifer Goldsack, CEO of the Digital Medicine Society for the first half of a far-reaching discussion about how big data is transforming healthcare. Healthcare innovators have been talking about being data-driven for a long time.
Pharmaceutical Commerce
AUGUST 19, 2022
Optimizing the use of data and improving the patient experience go hand in hand.
Pharmacy Times
AUGUST 19, 2022
Broncochem is an expectorant syrup to help cough symptoms.
Therapeutics Education Collaboration
AUGUST 19, 2022
In episode 518, Mike and James get Samantha to go through all the evidence we have for restricting lactose-containing foods in children with acute diarrhea. While we find out that looking at this evidence is at best tricky, it seems like reducing or diluting formula may provide a reasonable benefit. Listen to the podcast for the numbers. Show Notes.
Pharmacy Times
AUGUST 19, 2022
Professionals address key challenges including structural racism and the hematology-oncology pharmacist great migration.
Pharmaceutical Commerce
AUGUST 19, 2022
CDMO filling capacity now exceeds 50 million units yearly.
Pharma Times
AUGUST 19, 2022
NICE approval is for first-line treatment of intermediate and advanced renal cell carcinoma
Expert insights. Personalized for you.
132 
Let's personalize your content